{
    "organizations": [],
    "uuid": "a8db00e31a0a9c7502812466630ee9ed8ff6c5a8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-owner-of-harbin-pharmas-controllin/brief-owner-of-harbin-pharmas-controlling-shareholder-set-to-change-to-citic-capital-idUSH9N1QC002",
    "ord_in_thread": 0,
    "title": "BRIEF-Owner Of Harbin Pharma's Controlling Shareholder Set To Change To Citic Capital",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 23 (Reuters) - Harbin Pharmaceutical Group Co Ltd :\n* SAYS CONTROLLING SHAREHOLDERâ€˜S OWNER SET TO CHANGE TO CITIC CAPITAL FROM HARBIN STATE ASSET REGULATOR AFTER CAPITAL BOOST\n* SAYS CITIC CAPITAL WILL OWN 60.9 PERCENT STAKE IN ITS CONTROLLING SHAREHOLDER, HARBIN STATE ASSET REGULATOR'S STAKE WILL BE REDUCED TO 32.0 PERCENT Source text in Chinese: bit.ly/2osoLar Further company coverage: (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-02-23T22:55:00.000+02:00",
    "crawled": "2018-02-24T13:31:07.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "harbin",
        "pharmaceutical",
        "group",
        "co",
        "ltd",
        "say",
        "controlling",
        "shareholder",
        "owner",
        "set",
        "change",
        "citic",
        "capital",
        "harbin",
        "state",
        "asset",
        "regulator",
        "capital",
        "boost",
        "say",
        "citic",
        "capital",
        "percent",
        "stake",
        "controlling",
        "shareholder",
        "harbin",
        "state",
        "asset",
        "regulator",
        "stake",
        "reduced",
        "percent",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}